IMNM logo

Immunome, Inc. (IMNM) Shareholders Equity

Annual Shareholders Equity:

$181.16M+$61.28M(+51.12%)
December 31, 2024

Summary

  • As of today, IMNM annual stockholders equity is $181.16 million, with the most recent change of +$61.28 million (+51.12%) on December 31, 2024.
  • During the last 3 years, IMNM annual shareholders equity has risen by +$132.98 million (+275.98%).
  • IMNM annual shareholders equity is now at all-time high.

Performance

IMNM Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMbalance sheet metrics

Quarterly Shareholders Equity:

$269.27M-$37.86M(-12.33%)
June 30, 2025

Summary

  • As of today, IMNM quarterly stockholders equity is $269.27 million, with the most recent change of -$37.86 million (-12.33%) on June 30, 2025.
  • Over the past year, IMNM quarterly shareholders equity has increased by +$15.43 million (+6.08%).
  • IMNM quarterly shareholders equity is now -12.33% below its all-time high of $307.13 million, reached on March 31, 2025.

Performance

IMNM Quarterly Shareholders Equity Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherIMNMbalance sheet metrics

Shareholders Equity Formula

Shareholders Equity = Total Assets − Total Liabilities

IMNM Shareholders Equity Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+51.1%+6.1%
3Y3 Years+276.0%+789.4%
5Y5 Years+608.5%+2864.2%

IMNM Shareholders Equity Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Yearat high+987.9%-12.3%+4331.7%
5Y5-Yearat high+608.5%-12.3%+648.6%
All-TimeAll-Timeat high+608.5%-12.3%+648.6%

IMNM Shareholders Equity History

DateAnnualQuarterly
Jun 2025
-
$269.27M(-12.3%)
Mar 2025
-
$307.13M(+69.5%)
Dec 2024
$181.16M(+51.1%)
$181.16M(-15.7%)
Sep 2024
-
$214.91M(-15.3%)
Jun 2024
-
$253.84M(-11.1%)
Mar 2024
-
$285.57M(+138.2%)
Dec 2023
$119.88M(+619.9%)
$119.88M(+1873.0%)
Sep 2023
-
$6.08M(-34.9%)
Jun 2023
-
$9.34M(-32.6%)
Mar 2023
-
$13.86M(-16.8%)
Dec 2022
$16.65M
$16.65M(-27.9%)
DateAnnualQuarterly
Sep 2022
-
$23.08M(-23.8%)
Jun 2022
-
$30.28M(-20.1%)
Mar 2022
-
$37.87M(-21.4%)
Dec 2021
$48.19M(+16.5%)
$48.19M(-12.1%)
Sep 2021
-
$54.79M(-9.6%)
Jun 2021
-
$60.62M(+60.0%)
Mar 2021
-
$37.88M(-8.4%)
Dec 2020
$41.34M(+216.0%)
$41.34M(+184.2%)
Sep 2020
-
-$49.09M(-640.3%)
Jun 2020
-
$9.08M(+125.5%)
Dec 2019
-$35.63M(-41.4%)
-$35.63M
Dec 2018
-$25.20M
-

FAQ

  • What is Immunome, Inc. annual stockholders equity?
  • What is the all-time high annual shareholders equity for Immunome, Inc.?
  • What is Immunome, Inc. annual shareholders equity year-on-year change?
  • What is Immunome, Inc. quarterly stockholders equity?
  • What is the all-time high quarterly shareholders equity for Immunome, Inc.?
  • What is Immunome, Inc. quarterly shareholders equity year-on-year change?

What is Immunome, Inc. annual stockholders equity?

The current annual shareholders equity of IMNM is $181.16M

What is the all-time high annual shareholders equity for Immunome, Inc.?

Immunome, Inc. all-time high annual stockholders equity is $181.16M

What is Immunome, Inc. annual shareholders equity year-on-year change?

Over the past year, IMNM annual stockholders equity has changed by +$61.28M (+51.12%)

What is Immunome, Inc. quarterly stockholders equity?

The current quarterly shareholders equity of IMNM is $269.27M

What is the all-time high quarterly shareholders equity for Immunome, Inc.?

Immunome, Inc. all-time high quarterly stockholders equity is $307.13M

What is Immunome, Inc. quarterly shareholders equity year-on-year change?

Over the past year, IMNM quarterly stockholders equity has changed by +$15.43M (+6.08%)
On this page